These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12713869)

  • 1. p27(Kip1) is an independent predictor of recurrence after surgical resection in patients with small hepatocellular carcinoma.
    Armengol C; Boix L; Bachs O; Solé M; Fuster J; Sala M; Llovet JM; Rodés J; Bruix J
    J Hepatol; 2003 May; 38(5):591-7. PubMed ID: 12713869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
    Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
    Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p27, cyclin E and cyclin A in hepatocellular carcinoma and its clinical significance.
    Zhou Q; He Q; Liang LJ
    World J Gastroenterol; 2003 Nov; 9(11):2450-4. PubMed ID: 14606074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired expression of p27 is a favorable prognostic indicator in patients with hepatocellular carcinoma.
    Fiorentino M; Altimari A; D'Errico A; Cukor B; Barozzi C; Loda M; Grigioni WF
    Clin Cancer Res; 2000 Oct; 6(10):3966-72. PubMed ID: 11051245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p27(KIP1) and p21(WAF1/CIP1) in primary hepatocellular carcinoma: clinicopathologic correlation and survival analysis.
    Qin LF; Ng IO
    Hum Pathol; 2001 Aug; 32(8):778-84. PubMed ID: 11521219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of p16 contributes to p27 sequestration by cyclin D(1)-cyclin-dependent kinase 4 complexes and poor prognosis in hepatocellular carcinoma.
    Matsuda Y; Ichida T; Genda T; Yamagiwa S; Aoyagi Y; Asakura H
    Clin Cancer Res; 2003 Aug; 9(9):3389-96. PubMed ID: 12960127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell proliferation, apoptosis and the related regulators p27, p53 expression in hepatocellular carcinoma.
    Jing Z; Nan KJ; Hu ML
    World J Gastroenterol; 2005 Apr; 11(13):1910-6. PubMed ID: 15800979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells.
    Motomura W; Takahashi N; Nagamine M; Sawamukai M; Tanno S; Kohgo Y; Okumura T
    Int J Cancer; 2004 Jan; 108(1):41-6. PubMed ID: 14618613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
    Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S
    Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of p27 protein is associated with advanced tumor stage in hepatocellular carcinoma.
    Tannapfel A; Grund D; Katalinic A; Uhlmann D; Köckerling F; Haugwitz U; Wasner M; Hauss J; Engeland K; Wittekind C
    Int J Cancer; 2000 Jul; 89(4):350-5. PubMed ID: 10956409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CKS1B overexpression implicates clinical aggressiveness of hepatocellular carcinomas but not p27(Kip1) protein turnover: an independent prognosticator with potential p27 (Kip1)-independent oncogenic attributes?
    Huang CW; Lin CY; Huang HY; Liu HW; Chen YJ; Shih DF; Chen HY; Juan CC; Ker CG; Huang CY; Li CF; Shiue YL
    Ann Surg Oncol; 2010 Mar; 17(3):907-22. PubMed ID: 19866239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pRb2/p130, vascular endothelial growth factor, p27(KIP1), and proliferating cell nuclear antigen expression in hepatocellular carcinoma: their clinical significance.
    Claudio PP; Russo G; Kumar CA; Minimo C; Farina A; Tutton S; Nuzzo G; Giuliante F; Angeloni G; Maria V; Vecchio FM; Campli CD; Giordano A
    Clin Cancer Res; 2004 May; 10(10):3509-17. PubMed ID: 15161709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin dependent kinase inhibitor p27(kip1) expression and subcellular localization in relation to cell proliferation in hepatocellualr carcinoma.
    Shehata MA; Nosseir HR; Nagy HM; Farouk G
    Egypt J Immunol; 2006; 13(1):115-30. PubMed ID: 17974156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low CDX1 expression predicts a poor prognosis for hepatocellular carcinoma patients after hepatectomy.
    Zheng H; Yang Y; Wang MC; Yuan SX; Tian T; Han J; Ni JS; Wang J; Xing H; Zhou WP
    Surg Oncol; 2016 Sep; 25(3):171-7. PubMed ID: 27566019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin-dependent kinase inhibitor P27(KIP1) is expressed preferentially in early stages of urothelial carcinoma.
    Franke KH; Miklosi M; Goebell P; Clasen S; Steinhoff C; Anastasiadis AG; Gerharz C; Schulz WA
    Urology; 2000 Oct; 56(4):689-95. PubMed ID: 11018640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased p27(Kip1) expression and cyclin D1 overexpression, alone and in combination, influence recurrence and survival of patients with resectable extrahepatic bile duct carcinoma.
    Hui AM; Cui X; Makuuchi M; Li X; Shi YZ; Takayama T
    Hepatology; 1999 Nov; 30(5):1167-73. PubMed ID: 10534337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
    Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
    Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low expression of p27(Kip1) in advanced mucoepidermoid carcinomas of head and neck.
    Choi CS; Choi G; Jung KY; Choi JO; Chae YS
    Head Neck; 2001 Apr; 23(4):292-7. PubMed ID: 11400230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological expression of methionine adenosyl transferase (MAT) 2A as a post-surgical prognostic surrogate in patients with hepatocellular carcinoma.
    An J; Na SK; Shim JH; Park YS; Jun MJ; Lee JH; Song GW; Lee HC; Yu E
    J Surg Oncol; 2018 Apr; 117(5):892-901. PubMed ID: 29448301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.
    Calvisi DF; Ladu S; Pinna F; Frau M; Tomasi ML; Sini M; Simile MM; Bonelli P; Muroni MR; Seddaiu MA; Lim DS; Feo F; Pascale RM
    Gastroenterology; 2009 Nov; 137(5):1816-26.e1-10. PubMed ID: 19686743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.